Journal of Clinical Immunology最新文献

筛选
英文 中文
Somatic Mosaic NLRC4 Variants in Autoinflammatory Diseases: Functional Characterization and Correlation of Mosaicism Levels with Disease Age of Onset and Severity. 自身炎症疾病的体细胞镶嵌NLRC4变异:功能特征和镶嵌水平与疾病发病年龄和严重程度的相关性
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-07-08 DOI: 10.1007/s10875-025-01907-w
Farah Diab, Camille Louvrier, Marc Fabre, Christine Lin, Mira Rabbaa, Eman Assrawi, Aphrodite Daskalopoulou, Rahma Mani, Florence Dastot Le Moal, William Piterboth, Marie Legendre, Serge Amselem, Sonia Athina Karabina, Irina Giurgea
{"title":"Somatic Mosaic NLRC4 Variants in Autoinflammatory Diseases: Functional Characterization and Correlation of Mosaicism Levels with Disease Age of Onset and Severity.","authors":"Farah Diab, Camille Louvrier, Marc Fabre, Christine Lin, Mira Rabbaa, Eman Assrawi, Aphrodite Daskalopoulou, Rahma Mani, Florence Dastot Le Moal, William Piterboth, Marie Legendre, Serge Amselem, Sonia Athina Karabina, Irina Giurgea","doi":"10.1007/s10875-025-01907-w","DOIUrl":"10.1007/s10875-025-01907-w","url":null,"abstract":"","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"111"},"PeriodicalIF":7.2,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12238191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Treatment of Skin Dyskeratosis Due To NLRP1 Mutation Using Baricitinib. Baricitinib成功治疗NLRP1突变引起的皮肤角化不良。
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-07-05 DOI: 10.1007/s10875-025-01909-8
Gokce Vatansever, Zuhal Karali, Yasin Karali, Hasibe Artac, Sara Sebnem Kilic
{"title":"Successful Treatment of Skin Dyskeratosis Due To NLRP1 Mutation Using Baricitinib.","authors":"Gokce Vatansever, Zuhal Karali, Yasin Karali, Hasibe Artac, Sara Sebnem Kilic","doi":"10.1007/s10875-025-01909-8","DOIUrl":"10.1007/s10875-025-01909-8","url":null,"abstract":"","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"110"},"PeriodicalIF":7.2,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12228662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144567439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological and Immunogenetic Characterization in 8 Patients with Familial Hemophagocytic Lymphohistiocytosis Type 2: A Study from North India with Literature Review. 8例家族性2型嗜血球淋巴组织细胞病的临床病理和免疫遗传学特征:来自印度北部的一项研究并文献复习
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-06-19 DOI: 10.1007/s10875-025-01895-x
Saniya Sharma, Suprit Basu, Taru Goyal, Madhubala Sharma, Prabal Barman, Gurjit Kaur, Jitendra K Shandilya, Pandiarajan Vignesh, Rakesh Kumar Pilania, Ankur Kumar Jindal, Manpreet Dhaliwal, Prateek Bhatia, Sreejesh Sreedharanunni, Pulkit Rastogi, Nabhajit Mallik, Prashant Sharma, Anupriya Kaur, Deepti Suri, Amit Rawat, Surjit Singh
{"title":"Clinicopathological and Immunogenetic Characterization in 8 Patients with Familial Hemophagocytic Lymphohistiocytosis Type 2: A Study from North India with Literature Review.","authors":"Saniya Sharma, Suprit Basu, Taru Goyal, Madhubala Sharma, Prabal Barman, Gurjit Kaur, Jitendra K Shandilya, Pandiarajan Vignesh, Rakesh Kumar Pilania, Ankur Kumar Jindal, Manpreet Dhaliwal, Prateek Bhatia, Sreejesh Sreedharanunni, Pulkit Rastogi, Nabhajit Mallik, Prashant Sharma, Anupriya Kaur, Deepti Suri, Amit Rawat, Surjit Singh","doi":"10.1007/s10875-025-01895-x","DOIUrl":"10.1007/s10875-025-01895-x","url":null,"abstract":"<p><p>Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) is the commonest cause of familial hemophagocytic lymphohistiocytosis (FHLH). In this retrospective study, we analyzed 8 patients with a genetic diagnosis of FHL2 and then examined their clinicopathological and perforin flow cytometry results (< 10% expression). The atypical clinical features in our cohort included tuberculosis, lymphoreticular malignancy, and necrotizing enterocolitis in 3 patients. A disease-causing variant was identified in the PRF1 gene in all eight patients, comprising missense (n = 6), null (n = 1), and in-frame deletion (n = 1). Five patients had homozygous exon 3 disease-causing variants, two had homozygous exon 2 disease-causing variants, and one had compound heterozygous disease-causing variants in exon 2 and exon 3. After an extensive literature search, the mutations present in our North Indian cohort, including c.1284G > A, c.895C > T, c.853_855del, c.203G > A, and c.757G > A, are reported for the first time from India. Clinical and immunological phenotypes of c.1284G > A and c.203G > A variants have not been published in the literature. Hemophagocytosis was evident in bone marrow in 6 cases. Hyperferritinemia was absent in 3 cases, including c.148G > A, c. 895C > T, and c.1349C > T homozygous variants. Neurological involvement, lymphoreticular malignancy, and necrotizing enterocolitis were seen in 2, 1, and 1 cases, respectively. Infections were present in 4 cases. Five children succumbed to HLH, and three are alive and planned for a hematopoietic stem cell transplant. FHL2 should be suspected in children with HLH irrespective of the age of onset, atypical clinical phenotype, family history, ferritin and fibrinogen levels, and infections. Flow cytometry-based perforin assay helps in rapid diagnosis of FHL2.</p>","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"108"},"PeriodicalIF":7.2,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12178966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144325921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BK Virus-Specific T Cell Response Associated with HLA Genotypes, RhD Status, and CMV or EBV Serostatus in Healthy Donors for Optimized Cell Therapy. BK病毒特异性T细胞反应与HLA基因型、RhD状态、CMV或EBV血清状态相关,用于优化细胞治疗
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-06-19 DOI: 10.1007/s10875-025-01901-2
Rut Mora-Buch, Maria Tomás-Marín, Helena Pasamar, Emma Enrich, Cleofé Peña-Gómez, Francesc Rudilla
{"title":"BK Virus-Specific T Cell Response Associated with HLA Genotypes, RhD Status, and CMV or EBV Serostatus in Healthy Donors for Optimized Cell Therapy.","authors":"Rut Mora-Buch, Maria Tomás-Marín, Helena Pasamar, Emma Enrich, Cleofé Peña-Gómez, Francesc Rudilla","doi":"10.1007/s10875-025-01901-2","DOIUrl":"10.1007/s10875-025-01901-2","url":null,"abstract":"<p><strong>Purpose: </strong>The increasing application of virus-specific T cell therapy for treating BK virus infections in immunocompromised patients highlights the necessity for rapid identification of compatible cell donors with optimal BK-specific T cell response. This study aims to characterize the BK virus-specific T cell response in relation to demographic factors, blood group, serological status, and HLA genotypes using samples from a cell donor registry.</p><p><strong>Methods: </strong>Peripheral blood mononuclear cells from cell donors were stimulated with peptide pools derived from VP1 and LTA proteins, and the IFN-γ production was analyzed using ELISpot and validated by flow cytometry.</p><p><strong>Results: </strong>Our findings provide an overview of the T cell response to BK virus proteins in healthy donors, revealing associations with demographic characteristics, RhD status, CMV or EBV serological status, and HLA alleles. Remarkably, RhD-negative, CMV-seronegative, and EBV-seronegative donors showed a major T cell response against BK virus proteins. Notably, certain HLA alleles were associated with either enhanced or diminished T cell response. Furthermore, our results suggest that HLA-B leader dimorphism, specifically the presence of threonine at position 2, influences the VP1-specific immune response, resulting in enhanced T cell activation.</p><p><strong>Conclusion: </strong>This study, beyond advancing our understanding of the relationship between donor characteristics and BK virus-specific T cell response, has significant implications for improving the selection of optimal cell donors for patient-specific adoptive therapy.</p>","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"109"},"PeriodicalIF":7.2,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144333186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NET Proteomic Profiling Reveals New Pathways Potentially Implicated in Dendritic Cell-Mediated Inflammation in DADA2 Patients. NET蛋白质组学分析揭示了DADA2患者树突状细胞介导炎症的新途径。
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-06-16 DOI: 10.1007/s10875-025-01888-w
Sara Signa, Martina Bartolucci, Martina Bonacini, Arinna Bertoni, Genny Del Zotto, Anna Corcione, Andrea Petretto, Silvia Della Bella, Roberta Bertelli, Dario Di Silvestre, Andrea Lomagno, Pierluigi Mauri, Roberta Caorsi, Maurizio Bruschi, Simone Balin, Paola Bocca, Stefano Volpi, Maria Grazia Catanoso, Alessia Cafaro, Gino Tripodi, Lorenzo Pellottieri, Domenico Mavilio, Antonella Insalaco, Stefania Croci, Carlo Salvarani, Marco Gattorno, Francesca Schena
{"title":"NET Proteomic Profiling Reveals New Pathways Potentially Implicated in Dendritic Cell-Mediated Inflammation in DADA2 Patients.","authors":"Sara Signa, Martina Bartolucci, Martina Bonacini, Arinna Bertoni, Genny Del Zotto, Anna Corcione, Andrea Petretto, Silvia Della Bella, Roberta Bertelli, Dario Di Silvestre, Andrea Lomagno, Pierluigi Mauri, Roberta Caorsi, Maurizio Bruschi, Simone Balin, Paola Bocca, Stefano Volpi, Maria Grazia Catanoso, Alessia Cafaro, Gino Tripodi, Lorenzo Pellottieri, Domenico Mavilio, Antonella Insalaco, Stefania Croci, Carlo Salvarani, Marco Gattorno, Francesca Schena","doi":"10.1007/s10875-025-01888-w","DOIUrl":"10.1007/s10875-025-01888-w","url":null,"abstract":"<p><strong>Purpose: </strong>Adenosine deaminase 2 Deficiency (DADA2) is an autoinflammatory disease characterized by systemic vasculopathy, strokes and mild immunodeficiency. Recently NETosis has been implicated in the pathogenesis of Deficiency of Adenosine Deaminase 2. To deep investigate the possible effects of NETs on the immune system we characterized proteomic profile of NETs from DADA2 as compared to HD and Polyarteritis Nodosa (PAN) patients. To determine if NETs contain possibly immunogenic antigens we study functional aspects on Dendritic Cells after in vitro stimulation with NETs.</p><p><strong>Methods: </strong>Twenty-three DADA2 patients were enrolled. We analyzed NETosis by Imaging Flow Citometry. We evaluated NETs remnants and DNAse in the plasma samples by ELISA assay whereas DNAse activity by DNA digestion. We used quantitative proteomics approach and network analysis to identify NET proteins and pathways in 6 DADA2, 7 PAN and 7 HD. We analyzed circulating and monocyte-derived dendritic cells by flow cytometry.</p><p><strong>Results: </strong>Neutrophils from DADA2 patients show a significant increased suicidal NETosis. DNAse enzymes were not normal in the level or activity. By proteomic analysis we identified 1356 proteins among which a hundred of proteins were significantly up or down-modulated in DADA2 NETs as compared to normal and disease control NETs in resting condition and after stimulation with PMA, Adenosine and TNFα. DADA2 NETs are significantly more efficient than normal NETs in stimulating patients' monocyte-derived dendritic cells.</p><p><strong>Conclusion: </strong>We identified different pathways significantly modulated in DADA2 NETs versus PAN/HD NETs. This peculiar protein profile could contribute in activating inflammatory pathways in Dendritic cells in DADA2.</p>","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"106"},"PeriodicalIF":7.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12167720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144302208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Newborn Screening Followed By Early Treatment is Essential to Improve Survival in SCID. 更正:新生儿筛查和早期治疗对提高SCID患者的生存率至关重要。
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-06-16 DOI: 10.1007/s10875-025-01902-1
Gabriela Assunção Goebel, Luciana Araújo Oliveira Cunha, Fernanda Gontijo Minafra, Jorge Andrade Pinto
{"title":"Correction to: Newborn Screening Followed By Early Treatment is Essential to Improve Survival in SCID.","authors":"Gabriela Assunção Goebel, Luciana Araújo Oliveira Cunha, Fernanda Gontijo Minafra, Jorge Andrade Pinto","doi":"10.1007/s10875-025-01902-1","DOIUrl":"10.1007/s10875-025-01902-1","url":null,"abstract":"","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"107"},"PeriodicalIF":7.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144302207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Intravenous Immune Globulin 10% (BIVIGAM®) in Children with Primary Immune Deficiency. 静脉注射10%免疫球蛋白(BIVIGAM®)治疗原发性免疫缺陷儿童的安全性和有效性。
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-06-11 DOI: 10.1007/s10875-025-01891-1
Isaac Melamed, Jolan E Walter, Oral Alpan, Jennifer W Leiding
{"title":"Safety and Efficacy of Intravenous Immune Globulin 10% (BIVIGAM<sup>®</sup>) in Children with Primary Immune Deficiency.","authors":"Isaac Melamed, Jolan E Walter, Oral Alpan, Jennifer W Leiding","doi":"10.1007/s10875-025-01891-1","DOIUrl":"10.1007/s10875-025-01891-1","url":null,"abstract":"","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"105"},"PeriodicalIF":7.2,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unresolved Issues in Familial Mediterranean Fever: Is p.R202Q MEFV Variant Potentially Pathogenetic in Unleashing Inflammation? 家族性地中海热未解决的问题:p.R202Q MEFV变异是否具有释放炎症的潜在致病性?
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-06-10 DOI: 10.1007/s10875-025-01898-8
Chiara Baggio, Francesca Oliviero, Paola Galozzi, Irina Guidea, Andrea Doria, Roberta Ramonda, Sara Bindoli, Paolo Sfriso
{"title":"Unresolved Issues in Familial Mediterranean Fever: Is p.R202Q MEFV Variant Potentially Pathogenetic in Unleashing Inflammation?","authors":"Chiara Baggio, Francesca Oliviero, Paola Galozzi, Irina Guidea, Andrea Doria, Roberta Ramonda, Sara Bindoli, Paolo Sfriso","doi":"10.1007/s10875-025-01898-8","DOIUrl":"10.1007/s10875-025-01898-8","url":null,"abstract":"<p><p>Familial Mediterranean Fever (FMF) is caused by mutations in the MEFV gene, which encodes for pyrin. Although genetic testing is commonly employed for FMF diagnosis, the interpretation of genetic results is often challenging. Therefore, we aimed to functionally characterise the p.R202Q MEFV alteration. Furthermore, we hypothesized that inflammation may affect genomic stability and neutrophilic (N) subsets. A cohort comprising patients with FMF (n = 4), p.R202Q variant (n = 18) and FMF-like (n = 8) were selected from the Outpatient Clinic for Autoinflammatory diseases of Padova University Hospital. Primary monocytes were incubated for 3 h in the presence of LPS or LPS + PKN1/2 inhibitor (UCN-01). Colchicine pretreatment was applied to assess its anti-inflammatory effect. Pro-inflammatory cytokines were measured by ELISA and leukocytes were examined using May-Grünwald-Giemsa staining on blood smears. We did not find significant differences in IL-1 and IL-18 levels in monocytes treated with LPS + UCN-01 between p.R202Q patients and healthy donors (HDs). The levels of IL-1β released from LPS-stimulated patients were higher in p.R202Q patients than in HDs. We found that immature and hypersegmented neutrophils were higher in p.R202Q patients than in HD. Nuclear abnormalities were higher in FMF and p.R202Q patients than in HD. Finally, we found a higher cell rate in leukocytes from p.R202Q patients than in HDs. The p.R202Q variant did not appear to affect pyrin function, albeit these patients presented cytological alterations similar to those observed in FMF patients. These changes may contribute to FMF pathophysiology by influencing inflammation progression.</p>","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"104"},"PeriodicalIF":7.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144258179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Immunological Features of a Large DiGeorge Syndrome Cohort. 一个大型迪乔治综合征队列的临床和免疫学特征。
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-06-03 DOI: 10.1007/s10875-025-01884-0
Merve Süleyman, Deniz Cagdas, Pelin Özlem Şimşek Kiper, Gülen Eda Ütine, Merve Kaşıkcı Çavdar, Feyzi İlhan Tezcan
{"title":"Clinical and Immunological Features of a Large DiGeorge Syndrome Cohort.","authors":"Merve Süleyman, Deniz Cagdas, Pelin Özlem Şimşek Kiper, Gülen Eda Ütine, Merve Kaşıkcı Çavdar, Feyzi İlhan Tezcan","doi":"10.1007/s10875-025-01884-0","DOIUrl":"10.1007/s10875-025-01884-0","url":null,"abstract":"<p><strong>Background: </strong>DiGeorge Syndrome (DGS), a microdeletion syndrome, shows a broad spectrum from mild T-cell lymphopenia to severe combined immunodeficiency.</p><p><strong>Aim: </strong>To define the clinical/immunophenotypical biomarkers for DGS.</p><p><strong>Patients and methods: </strong>A total of 72 patients with 22q11.2 deletion(n = 66) and those fulfilling the DGS criteria without deletion (n = 6) were enrolled.</p><p><strong>Results: </strong>The male/female ratio was 41/31. Median age at clinical diagnosis was 1.7 years (0 days-22 years) with follow-up for 21.7 months (0 days-17.3 years). Common evaluation reasons were cardiac features (30.6%), failure to thrive (15.3%), and neurological features (15.3%). Craniofacial dysmorphism (64/66, 97%), central nervous system findings (62/72, 86.1%), and congenital cardiovascular defect (43/70, 61.4%) were common. We noted lymphopenia (30/72, 41.7%) and low IgM (25/69, 36.2%). T helper cell counts were low in 49.3% (33/67). T cytotoxic and NK cell counts were normal/high in 80.6% (54/67) and 97% (65/67) of patients, respectively. 42.3% (11/26) had low CD4 + TEMRA, and 34.6% (9/26) had low CD8 + TEM percentages. None had low CD8 + TEMRA. B cells were normal/high (52/67, 77.6%). 30.8%(8/26) had low switched-memory and 38.5% (10/26) had low active B cell percentages. Low IgA levels were associated with decreased lymphocyte activation and recent thymic emigrant (RTE) cell percentages. Six(8.3%) patients with lymphopenia, three of whom had congenital athymia, died.</p><p><strong>Conclusion: </strong>CD4 lymphopenia was more common than CD8 lymphopenia. Normal/high CD8 + and NK cell counts were remarkable. Increased CD8+ TEMRA cells seem to indicate peripheral homeostatic proliferation following viral infections. Low serum IgA correlated with low RTE% and impaired T-cell function. DGS severity markers include hypocalcemia, congenital cardiac anomaly, and T-cell lymphopenia.</p>","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"103"},"PeriodicalIF":7.2,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12133924/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144215994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetics in a Danish Common Variable Immunodeficiency Cohort. 丹麦共同可变免疫缺陷队列的遗传学研究。
IF 7.2 2区 医学
Journal of Clinical Immunology Pub Date : 2025-06-02 DOI: 10.1007/s10875-025-01896-w
Camilla Heldbjerg Drabe, Mira Marie Laustsen, Hanne Vibeke Marquart, Hans Jakob Hartling, Rasmus L Marvig, Jannik Helweg-Larsen, Ann-Brit Eg Hansen, Jens Lundgren, Marie Helleberg, Line Borgwardt, Terese L Katzenstein
{"title":"Genetics in a Danish Common Variable Immunodeficiency Cohort.","authors":"Camilla Heldbjerg Drabe, Mira Marie Laustsen, Hanne Vibeke Marquart, Hans Jakob Hartling, Rasmus L Marvig, Jannik Helweg-Larsen, Ann-Brit Eg Hansen, Jens Lundgren, Marie Helleberg, Line Borgwardt, Terese L Katzenstein","doi":"10.1007/s10875-025-01896-w","DOIUrl":"10.1007/s10875-025-01896-w","url":null,"abstract":"","PeriodicalId":15531,"journal":{"name":"Journal of Clinical Immunology","volume":"45 1","pages":"102"},"PeriodicalIF":7.2,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信